Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and Children
The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Abstract
Background Prediction of the exposure of neonates, infants and children to xenobiotics is likely to be more successful using physiologically based pharmacokinetic models than simplistic allometric scaling, particularly in younger children. However, such models require comprehensive information on the ontogeny of anatomical, physiological and biochemical variables; data that are not available from single sources. The Simcyp software integrates demographic, genetic, physiological and pathological information on adults with in vitro data on human drug metabolism and transport to predict population distributions of drug clearance (CL) and the extent of metabolic drug-drug interactions. The algorithms have now been extended to predict clearance and its variability in paediatric populations by incorporating information on developmental physiology and the ontogeny of specific cytochrome P450s.Methods Values of the clearance (median and variability) of 11 drugs (midazolam [oral and intravenous], caffeine, carbamazepine, cisapride, theophylline, diclofenac, omeprazole, S-warfarin, phenytoin, gentamicin and vancomycin) were predicted for 2,000 virtual subjects (birth to 18 years). In vitro enzyme pharmacokinetic parameters (maximum rate of metabolism [Vmax] and Michaelis-Menten constant [Km]) and in vivo clearance data were obtained from the literature.Results In neonates 70% (7/10) of predicted median clearance values were within 2-fold of the observed values. Corresponding results for infants, children and adolescents were 100% (9/9), 89% (17/19) and 94% (17/18), respectively. Predicted variability (95% confidence interval) was within 2-fold of the observed values in 70% (7/10), 67% (6/9), 63% (12/19) and 55% (10/18) of cases, respectively. The accuracy of the physiologically based model incorporated in the Simcyp software was superior to that of simple allometry, especially in children <2 years old.Conclusion The in silico prediction of pharmacokinetic behaviour in paediatric patients is not intended to replace clinical studies. However, it provides a valuable aid to decision-making with regard to first-time dosing in children and study design. The clinical study then becomes 'confirmatory' rather than 'exploratory'.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population PBPK models that embed age-dependent physiology (organ volumes, blood flows, enzyme expression, and renal function) can simulate pediatric exposures and justify bridging strategies based on adult data [22,88,89].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [89]
In the citing paper
“CYP3A4, for example, matures over the first year of life, while CYP1A2 and CYP2D6 exhibit distinct developmental trajectories.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [89]
In the citing paper
“Generalization beyond healthy adults requires explicit consideration of physiological diversity that simple allometric scaling cannot capture [22,87,88,89].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [89]
In the citing paper
“Pediatric dosing should incorporate enzyme and transporter ontogeny rather than rely on simple weight- or BSA-based exponents [88,89].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [89]
Citations
Cites
Textbook of Medical Physiology
(1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-6-1363_2 · Cited by 9,749
A formula to estimate the approximate surface area if height and weight be known. 1916.
Bois, D. D., & Bois, E. F. D. (1989) · PubMed · Cited by 5,706
Du BOIS, D. (1916) · Archives of Internal Medicine · doi:10.1001/archinte.1916.00080130010002 · Cited by 4,342
Information Theory and an Extention of the Maximum Likelihood Principle
(1973) · IEEE International Symposium on Information Theory (ISIT) · Cited by 2,794
Schwartz, G. J., Haycock, G. B., Edelmann, C. M., & Spitzer, A. (1976) · Pediatrics · doi:10.1542/peds.58.2.259 · Cited by 2,379
Information theory as an extension of the maximum likelihood principle
Akaike, H. (1973) · Medical Entomology and Zoology · Cited by 2,357
Clinical pharmacokinetics; concepts and applications
(1989) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(89)90348-0 · Cited by 2,223
Body mass index reference curves for the UK, 1990.
Cole, T. J., Freeman, J. V., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.25 · Cited by 2,047
Valentin, J. (2002) · Annals of the ICRP · doi:10.1016/s0146-6453(03)00002-2 · Cited by 1,754
Haycock, G. B., Schwartz, G. J., & Wisotsky, D. H. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80601-5 · Cited by 1,675
Research works printed but not linked: 8
- Yang, 2001, Br J Clin Pharmacol, 52, 472P
- Rowland-Yeo, 2003, Br J Clin Pharmacol, 57, 687
- Traub, 1980, Am J Hosp Pharm, 37, 195
- Nau, 1983, Pediatr Pharmacol (New York), 3, 219
- Valetin, 2002, Ann ICRP, 32, 5
- Yang, 2001, Br J Clin Pharmacol, 52, 472P
- Wilkinson, 1987, Pharmacol Rev, 39, 1
- Kearns, 1999, Paediatr Perinat Drug Ther, 3, 9
Cited by
Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
Anderson, B. J., & Holford, N. H. G. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094708 · Cited by 1,125
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Self-citationBasic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
Jones, H., & Rowland‐Yeo, K. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.41 · Cited by 626
To Scale or Not to Scale: The Principles of Dose Extrapolation
Sharma, V., & McNeill, J. H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00267.x · Cited by 544
“PBPK modelling would be the superior method to use (Ginsberg et al., 2004; Bjorkman, 2005; Johnson et al., 2006).”
MethodSimulation and prediction of in vivo drug metabolism in human populations from in vitro data
Rostami-Hodjegan, A., & Tucker, G. T. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2173 · Cited by 530
“Data on developmental changes in the abundance and activity of different CYPs can also be incorporated into the models to predict hepatic clearance in neonates, infants and childre”
MethodSelf-citation
Metadata
- Authors
- Johnson, T. N., Rostami-Hodjegan, A., & Tucker, G. T.
- Affiliations
- Simcyp (United Kingdom) (GB)
- Royal Hallamshire Hospital (GB)
- Corresponding author
- Johnson, Trevor N
- Venue
- Clinical Pharmacokinetics
- Published
- 2006
- Volume
- 45
- Issue
- 9
- Pages
- 931-956
- ISSN
- 0312-5963 (ISSN-L)
- OpenAlex
- W1968101595
- Cited by
- 530
- References
- 172
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 28 · 2023: 22 · 2022: 28 · 2021: 22 · 2020: 28 · 2019: 38 · 2018: 37 · 2017: 28 · 2016: 33 · 2015: 26 · 2014: 38 · 2013: 29 · 2012: 30
- FWCI
- 16.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacokinetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- pediatric pharmacokinetics, drug clearance prediction, SimCYP, physiologically based pharmacokinetic modelling, cytochrome P450, allometric scaling, midazolam, caffeine, carbamazepine, cisapride, theophylline, diclofenac, omeprazole, S-warfarin, phenytoin, gentamicin, vancomycin, in silico prediction
- MeSH terms
- Algorithms, Caffeine, Carbamazepine, Child, Computer Simulation, Humans, Infant, Infant, Newborn, Metabolic Clearance Rate, Midazolam, Models, Biological, Monte Carlo Method, Software
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and Children. https://app.cochat.ai/papers/10.2165/00003088-200645090-00005
- The paper
- Johnson, T. N., Rostami-Hodjegan, A., & Tucker, G. T. (2006). Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and Children. Clinical Pharmacokinetics. https://doi.org/10.2165/00003088-200645090-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.